Hetero Labs Limited
UkraineAll drugs from this manufacturer
-
The drug is used as part of combination antiretroviral therapy for the treatment of HIV infection in adults and children weighing 25 kg or more.
Dosage form: tablets, film-coated
Active substance Dosage abacavir 600 mg lamivudine 300 mg ATC: J05AR02
-
The drug is used as part of combination antiretroviral therapy for the treatment of HIV infection in adults and children.
Dosage form: solution, oral
Active substance Dosage abacavir 20 mg/ml ATC: J05AF06
-
The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed hormone-sensitive (high risk), castration-resistant with mild course, or those progressing after docetaxel chemotherapy.
Dosage form: tablets
Active substance Dosage abiraterone 250 mg ATC: L02BX03
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with bortezomib and dexamethasone or with dexamethasone alone, depending on the patient's previous treatment experience.
Dosage form: capsules
Active substance Dosage pomalidomide 1 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used either in combination with bortezomib and dexamethasone, or in combination with dexamethasone (depending on the patient's previous treatment experience).
Dosage form: capsules
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used either in combination with bortezomib and dexamethasone, or with dexamethasone alone, depending on the patient's previous treatment experience.
Dosage form: capsules
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
The drug is intended for the treatment of adult patients with multiple myeloma. It is used either in combination with bortezomib and dexamethasone, or in combination with dexamethasone, depending on the patient's previous treatment experience.
Dosage form: capsules
Active substance Dosage pomalidomide 4 mg ATC: L04AX06
-
The drug is prescribed to women during postmenopause for adjuvant treatment of hormone receptor-positive invasive breast cancer (both in early stages and after tamoxifen therapy), as well as for the treatment of advanced hormone receptor-positive breast cancer.
Dosage form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
-
The drug is used for the treatment of schizophrenia in adults, as well as for the treatment of moderate to severe manic episodes in bipolar I disorder. It is also used to prevent new manic episodes in adults who have previously responded to treatment with this agent.
Dosage form: tablets
Active substance Dosage aripiprazole 5 mg ATC: N05AX12
-
The drug is used for the treatment of schizophrenia in adults, as well as for the treatment of moderate and severe manic episodes in bipolar I disorder. It is also used to prevent new manic episodes in adults who have previously responded to treatment with this medication.
Dosage form: tablets
Active substance Dosage aripiprazole 10 mg ATC: N05AX12
-
The drug is intended for the treatment of adults and children aged 6 years and older infected with the human immunodeficiency virus (HIV-1), in combination with ritonavir and other antiretroviral agents.
Dosage form: capsules, hard
Active substance Dosage atazanavir 150 mg ATC: J05AE08
-
The drug is intended for the treatment of adults and children aged 6 years and older infected with the human immunodeficiency virus (HIV-1), in combination with ritonavir and other antiretroviral agents.
Dosage form: capsules, hard
Active substance Dosage atazanavir 200 mg ATC: J05AE08
-
The drug is intended for the treatment of adults and children aged 6 years and older infected with the human immunodeficiency virus (HIV-1), in combination with ritonavir and other antiretroviral agents.
Dosage form: capsules, hard
Active substance Dosage atazanavir 300 mg ATC: J05AE08
-
The drug is used for the symptomatic treatment of benign prostatic hyperplasia (BPH).
Dosage form: capsules
Active substance Dosage silodosin 4 mg ATC: G04CA04
-
The drug is used for the treatment of neuropathic pain (of peripheral or central origin), epilepsy (as adjunctive therapy for partial seizures), generalized anxiety disorder, and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 75 mg ATC: N03AX16
-
The drug is indicated for the treatment of neuropathic pain (of peripheral or central origin), epilepsy (as adjunctive treatment for partial seizures), generalized anxiety disorder, and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 150 mg ATC: N03AX16
-
The drug is used for the treatment of neuropathic pain (of peripheral or central origin) in adults, as adjunctive therapy in epilepsy (partial seizures), and for the treatment of generalized anxiety disorder and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 300 mg ATC: N03AX16
-
The drug is used for the therapy of chronic lymphocytic leukemia, as well as for the treatment of advanced stages of indolent non-Hodgkin lymphomas (as part of combination therapy).
Dosage form: lyophilisate for solution for injection
Active substance Dosage bendamustine 25 mg ATC: L01AA09
-
The drug is used for the therapy of chronic lymphocytic leukemia, as well as for the treatment of advanced stages of indolent non-Hodgkin lymphomas (as part of combination therapy).
Dosage form: lyophilisate for solution for injection
Active substance Dosage bendamustine 100 mg ATC: L01AA09
-
The drug is used for the treatment of advanced prostate cancer in combination with surgical castration or with luteinizing hormone-releasing hormone (LHRH) analogues.
Dosage form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg ATC: L02BB03
-
The drug is prescribed for the treatment of patients with locally advanced prostate cancer (without metastases). It is used as monotherapy or as an adjunct to surgical intervention (radical prostatectomy) or radiotherapy in cases of high risk of disease progression.
Dosage form: tablets, film-coated
Active substance Dosage bicalutamide 150 mg ATC: L02BB03
-
The drug is used for the treatment and control of benign prostatic hyperplasia (BPH). It helps to reduce the size of the enlarged gland, improve urine flow, reduce symptoms, and lower the risk of acute urinary retention or the need for surgical intervention.
Dosage form: tablets, film-coated
Active substance Dosage finasteride 5 mg ATC: G04CB01
-
The drug is used to treat arterial hypertension (high blood pressure), as well as an adjunct to standard therapy in patients aged 70 years and older with mild to moderate chronic heart failure.
Dosage form: tablets
Active substance Dosage nebivolol 5 mg ATC: C07AB12
-
The drug is used for the treatment of multiple myeloma (both as part of combination therapy and as monotherapy, depending on the stage of the disease) and mantle cell lymphoma.
Dosage form: lyophilisate for solution for injection
Active substance Dosage bortezomib 3.5 mg ATC: L01XX32
-
The drug is used for the treatment of colon cancer (colorectal cancer) and stomach cancer. It is also used for breast cancer.
Dosage form: tablets, film-coated
Active substance Dosage capecitabine 150 mg ATC: L01BC06
-
The drug is used for the treatment of colon cancer (colorectal cancer), stomach cancer, and breast cancer.
Dosage form: tablets, film-coated
Active substance Dosage capecitabine 500 mg ATC: L01BC06
-
The drug is used for the symptomatic treatment of urticaria and allergic rhinitis (including perennial allergic rhinitis).
Dosage form: tablets, film-coated
Active substance Dosage levocetirizine 5 mg ATC: R06AE09
-
The drug is prescribed for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease undergoing dialysis. It is also used to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Dosage form: tablets, film-coated
Active substance Dosage cinacalcet 30 mg ATC: H05BX01
-
The drug is used to treat secondary hyperparathyroidism in patients with end-stage renal disease undergoing dialysis. It is also prescribed to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Dosage form: tablets, film-coated
Active substance Dosage cinacalcet 60 mg ATC: H05BX01
-
The drug is used to treat secondary hyperparathyroidism in patients with end-stage renal disease undergoing dialysis. It is also prescribed to lower calcium levels in cases of parathyroid carcinoma or primary hyperparathyroidism if surgery is impossible or contraindicated.
Dosage form: tablets, film-coated
Active substance Dosage cinacalcet 90 mg ATC: H05BX01
-
The drug is used for the prevention and treatment of gout attacks in adults, as well as for the treatment of familial Mediterranean fever (FMF) in adults and children aged 4 years and older.
Dosage form: tablets, film-coated
Active substance Dosage colchicine 0.6 mg ATC: M04AC01
-
The drug is used for the treatment of adults and children aged 12 years and older (weighing 40 kg or more) who are infected with the human immunodeficiency virus (HIV).
Dosage form: tablets, film-coated
Active substance Dosage abacavir 600 mg dolutegravir 50 mg lamivudine 300 mg ATC: J05AR13
-
The drug is intended for the treatment of patients infected with the human immunodeficiency virus (HIV-1). It is used in combination with other antiretroviral agents and specific substances (ritonavir or cobicistat) that enhance its efficacy.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 400 mg ATC: J05AE10
-
The drug is intended for the treatment of patients infected with the human immunodeficiency virus (HIV-1). It is used in combination with low-dose ritonavir and other antiretroviral agents.
Dosage form: tablets, film-coated
Active substance Dosage darunavir 600 mg ATC: J05AE10
-
The drug is used for the treatment of major depressive disorder, generalized anxiety disorder, as well as diabetic peripheral neuropathic pain.
Dosage form: capsules, gastro-resistant
Active substance Dosage duloxetine 30 mg ATC: N06AX21
-
The drug is used for the treatment of major depressive disorder, generalized anxiety disorder, as well as diabetic peripheral neuropathic pain.
Dosage form: capsules, gastro-resistant
Active substance Dosage duloxetine 60 mg ATC: N06AX21
-
The drug is used to treat adults and children (from 1 year of age) with chronic immune (idiopathic) thrombocytopenic purpura (ITP) that is unresponsive to other treatments. It is also prescribed for the treatment of thrombocytopenia in patients with chronic hepatitis C and adults with severe aplastic anemia.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 25 mg ATC: B02BX05
-
The drug is used to treat adults and children (from 1 year of age) with chronic immune (idiopathic) thrombocytopenic purpura (ITP) that is unresponsive to other treatments. It is also prescribed for the treatment of thrombocytopenia in patients with chronic hepatitis C and for adults with severe aplastic anemia.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 50 mg ATC: B02BX05
-
The drug is used for the treatment of adults and children (from 1 year of age) with chronic immune (idiopathic) thrombocytopenia that is unresponsive to other treatments. It is also prescribed to adults for the treatment of thrombocytopenia associated with chronic hepatitis C and to adults with severe aplastic anemia.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 75 mg ATC: B02BX05
-
The drug is used as a full treatment regimen for human immunodeficiency virus type 1 (HIV-1) infection in adults and children weighing at least 35 kg.
Dosage form: tablets, film-coated
Active substance Dosage efavirenz 400 mg lamivudine 300 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR11
-
The drug is prescribed as part of combination therapy for the treatment of HIV-1 infection in adults and adolescents (from 12 years of age weighing at least 35 kg). It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection through sexual contact in adults and adolescents at high risk.
Dosage form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg ATC: J05AR03
-
The drug is intended for the treatment of chronic hepatitis B virus infection in adults and children aged 2 to 18 years with compensated liver disease. It is also used for the treatment of adults with decompensated liver disease.
Dosage form: tablets, film-coated
Active substance Dosage entecavir 0.5 mg ATC: J05AF10
-
The drug is intended for the treatment of chronic hepatitis B virus in adults and children aged 2 to 18 years with compensated liver disease. It is also used for adults with decompensated liver disease.
Dosage form: tablets, film-coated
Active substance Dosage entecavir 1 mg ATC: J05AF10
-
The drug is prescribed for the treatment of non-small cell lung cancer (as first-line therapy, for maintenance therapy, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC: L01EB02
-
The drug is used for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, for maintenance therapy, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC: L01EB02
-
The drug is used for the treatment of non-small cell lung cancer (as first-line therapy, for maintenance treatment, or after ineffective chemotherapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.
Dosage form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC: L01EB02
-
The drug is used as part of combination therapy for the treatment of diseases caused by the human immunodeficiency virus (HIV-1) in adults, adolescents, and children weighing 40 kg or more.
Dosage form: tablets, film-coated
Active substance Dosage efavirenz 600 mg ATC: J05AG03
-
The drug is used to lower cholesterol levels in primary hypercholesterolemia (as an adjunct to diet if statins are insufficient or unsuitable), as well as to prevent cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also indicated for homozygous familial hypercholesterolemia and sitosterolemia.
Dosage form: tablets
Active substance Dosage ezetimibe 10 mg ATC: C10AX09
-
The drug is used for the treatment of erosive reflux esophagitis, prevention of esophagitis recurrence, and symptomatic treatment of gastroesophageal reflux disease (GERD). It is also used for the treatment of gastric and duodenal ulcers (including those caused by Helicobacter pylori or the use of anti-inflammatory drugs), Zollinger–Ellison syndrome, and for the prevention of ulcer bleeding.
Dosage form: tablets, enteric-coated
Active substance Dosage esomeprazole 20 mg ATC: A02BC05
-
The drug is used for the treatment of erosive reflux esophagitis, the prevention and treatment of gastric and duodenal ulcers (including those caused by non-steroidal anti-inflammatory drugs or Helicobacter pylori bacteria), as well as for the treatment of Zollinger–Ellison syndrome.
Dosage form: tablets, enteric-coated
Active substance Dosage esomeprazole 40 mg ATC: A02BC05